0.1141
+0.0141
+(14.10%)
At close: January 21 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-21,537.0000
-21,948.0000
-22,557.0000
-19,548.0000
Investing Cash Flow
2.0000
-48.0000
-163.0000
-459.0000
Financing Cash Flow
20,392.0000
22,155.0000
22,486.0000
20,159.0000
End Cash Position
329.0000
276.0000
117.0000
351.0000
Interest Paid Supplemental Data
--
241.0000
35.0000
--
Capital Expenditure
-33.0000
-48.0000
-163.0000
-459.0000
Issuance of Capital Stock
2,541.0000
1,668.0000
--
63.0000
Issuance of Debt
22,616.0000
26,506.0000
23,000.0000
20,500.0000
Repayment of Debt
-2,098.0000
-300.0000
-675.0000
-404.0000
Free Cash Flow
-21,570.0000
-21,996.0000
-22,720.0000
-20,007.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
688278.SS Xiamen Amoytop Biotech Co., Ltd.
80.88
+0.99%
TCBPW TC Biopharm (Holdings) Plc
0.0135
+0.75%
PBMWW Psyence Biomedical Ltd.
0.0197
-17.23%
SABSW SAB Biotherapeutics, Inc.
0.0368
+15.00%
CEROW CERo Therapeutics Holdings, Inc.
0.0179
+18.54%
WXXWY WuXi Biologics (Cayman) Inc.
4.7800
+0.63%
TFFP TFF Pharmaceuticals, Inc.
0.0650
-60.05%
MTVA MetaVia Inc.
1.8100
-8.12%
XBIO Xenetic Biosciences, Inc.
4.3100
+0.70%
INAB IN8bio, Inc.
0.2558
+3.19%